Trial Profile
Serum HBsAg Levels at baseline and on treatment to predict its association with therapeutic outcome to entecavir in chronic hepatitis B patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 23 Dec 2015 New trial record